Patent · US Active

Tricyclic compound and pharmaceutical use thereof

US8236837B2 · kind B2 · utility

3Cited by
9References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 14, 2011
Grant dateAug 7, 2012
Priority date
Expiry dateMar 14, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a compound represented by the formulawhich is useful as an agent for the prophylaxis or treatment of diseases related to the action of melatonin, or a salt thereof and the like.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.